COMP <GO>
EXPO vs PG // EV/EBITDA & P/E VALUATION
Exponent Inc. (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: EXPO 6
— PG 9
▲ EV/EBITDA & P/E VALUATION LEADER: PG
LAST: $80.26 (+2.49%) • MKT CAP: $3.72B
valuation
28.7x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EXPO VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EXPO | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.60% | 25.40% | +3.20 | EXPO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 28.7x | 16.2x | +12.50 | PG | /valuation <GO> |
| Free Cash Flow Yield | 3.29% | 3.77% | -0.48 | PG | /fcf-yield <GO> |
| Operating Margin | 20.60% | 24.30% | -3.70 | PG | /operating-margins <GO> |
| Net Profit Margin | 18.20% | 19.00% | -0.80 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 4.20% | 0.30% | +3.90 | EXPO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.65% | 2.65% | -1.00 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.62 | 5.59 | +3.03 | EXPO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | EXPO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.50% | +0.20 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 78.4 | 62.7 | +15.69 | EXPO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.87 | +0.07 | EXPO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.6x | 21.7x | +10.90 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.72B | $372.21B | -$368.49B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EXPO REV | PG REV | EXPO GROSS % | PG GROSS % | EXPO FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $582.0M | $84.28B | 44.0% | 51.2% | $122.3M | $14.04B |
| FY 2024 | $558.5M | $84.04B | 44.0% | 51.4% | $137.6M | $16.52B |
| FY 2023 | $536.8M | $82.01B | 44.0% | 44.0% | $103.2M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EXPO // BETA 0.94
PG // BETA 0.87